🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fiasp Closed-Loop System

Found 36 matching trials

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

PHASE2

In previous studies, investigators have studied if a pre-meal insulin bolus...

Status

Completed

Location

Institut de recherches cliniques de Montréal

Start Date

2016-06

Trial ID

NCT02798250

Treatments Being Tested

Dual-hormone closed-loop Insulin Glucagon Dexcom G4 Platinum glucose sensor Accu Chek Combo insulin pump

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

PHASE2

In previous studies, investigators have studied if a pre-meal insulin bolus...

Status

Completed

Location

Institut de recherches cliniques de Montréal

Start Date

2016-01

Trial ID

NCT02626936

Treatments Being Tested

Dual-hormone closed-loop Insulin Glucagon Dexcom G4 Platinum glucose sensor Accu Chek Combo insulin pump

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

PHASE2

Closed-loop strategy is composed of three components: glucose sensor to rea...

Status

Withdrawn

Location

Multiple Locations

Start Date

TBD

Trial ID

NCT02846857

Treatments Being Tested

15-week intervention with sensor-augmented pump 15-week intervention with single-hormone closed-loop 15-week intervention with dual-hormone closed-loop Insulin pump Continuous glucose monitoring system Insulin Glucagon

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp

PHASE2

Closed-loop strategy is composed of three components: glucose sensor to rea...

Status

Completed

Location

Institut de recherches cliniques de Montréal

Start Date

2014-06

Trial ID

NCT02189694

Treatments Being Tested

Single-hormone closed-loop strategy Dual-hormone closed-loop strategy Insulin pump therapy

Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

PHASE2

Closed-loop system systems that are shown to alleviate the burden of carboh...

Status

Completed

Location

McGill University Health Centre

Start Date

2019-02-08

Trial ID

NCT03800875

Treatments Being Tested

27-hour inpatient intervention

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

PHASE2

Regular physical activity is associated with many health benefits for indiv...

Status

Completed

Location

Institut de recherches cliniques de Montréal

Start Date

2016-09

Trial ID

NCT02855307

Treatments Being Tested

60-minute exercise Insulin pump Dexcom G4 Platinum glucose sensor Insulin Single-hormone closed-loop strategy

Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

PHASE2

The iLet™ is a new insulin pump that is programmed to work with a Continuou...

Status

Completed

Location

Novo Nordisk Investigational Site

Start Date

2019-02-25

Trial ID

NCT03816761

Treatments Being Tested

Fast-acting insulin aspart iLet™

Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes

PHASE2

Closed-loop strategy is composed of three components: glucose sensor to rea...

Status

Completed

Location

Mount Sinai Hospital

Start Date

2013-07

Trial ID

NCT01905020

Treatments Being Tested

Carbohydrate-rich meal Exercise

FASter Insulin in Closed-loop Technology in Children

The main objective of this study is to determine whether 24/7 hybrid closed...

Status

Completed

Location

University Department of Paediatrics

Start Date

2021-03-12

Trial ID

NCT04759144

Treatments Being Tested

CamAPS FX using faster insulin aspart CamAPS FX using standard insulin aspart

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Postprandial glycemic excursions are major determinants of overall glycemic...

Status

Completed

Location

Montreal Clinical Research Institute

Start Date

2020-07-10

Trial ID

NCT04031599

Treatments Being Tested

Single-hormone closed-loop system Insulin pump Continuous glucose monitoring system Aspart or Lispro Carbohydrate counting Simplified qualitative meal-size estimation strategy 3-week intervention 1-hour postprandial exercise (sub-study)2-hour postprandial exercise (sub-study)Exercise announcement and meal bolus reduction (sub-study)

Previous Next